Thrombocytopenia After Gemtuzumab Is Reversible by Intravenous Immunoglobulin
Leukemia- United Kingdom
doi 10.1038/sj.leu.2403757
Full Text
Abstract
Available in
Date
April 7, 2005
Authors
Publisher
Springer Science and Business Media LLC
doi 10.1038/sj.leu.2403757
Available in
April 7, 2005
Springer Science and Business Media LLC